Originally published In Press as doi:10.1074/jbc.M002701200 on June 22, 2000
J. Biol. Chem., Vol. 275, Issue 35, 26925-26934, September 1, 2000
The TATA-binding Protein-associated Factor
yTafII19p Functionally Interacts with Components of the
Global Transcriptional Regulator Ccr4-Not Complex and Physically
Interacts with the Not5 Subunit*
Marc
Lemaire
and
Martine A.
Collart§
From the Département de Biochimie Médicale,
Céntre Médical Universitaire, 1 rue Michel
Servet, 1211 Geneva 4, Switzerland
Received for publication, March 28, 2000, and in revised form, May 31, 2000
 |
ABSTRACT |
The Saccharomyces cerevisiae HIS3
gene is a model system to characterize transcription initiation from
different types of core promoters. The NOT genes were
identified by mutations that preferentially increased transcription of
the HIS3 promoter lacking a canonical TATA sequence. They
encode proteins associated in a complex that also contains the Caf1 and
Ccr4 proteins. It has been suggested that the Ccr4-Not complex
represses transcription by inhibiting factors more specifically
required for promoters lacking a TATA sequence. A potential target is
the yTafII19 subunit of TFIID, which, when depleted,
leads to a preferential decrease of HIS3 TATA-less
transcription. We isolated conditional taf19 alleles
that display synthetic growth phenotypes when combined with
not4 or specific not5 alleles. Inactivation of
yTafII19p by shifting these mutants to the restrictive
temperature led to a more rapid and striking decrease in transcription
from promoters that do not contain a canonical TATA sequence. We
demonstrated by the two-hybrid assay and directly in
vitro that yTafII19p and Not5p could interact.
Finally, we found by the two-hybrid assay that yTafII19p
also interacted with many components of the Ccr4-Not complex. Taken
together, our results provide evidence that interactions between Not5p
and yTafII19p may be involved in transcriptional regulation
by the Ccr4-Not complex.
 |
INTRODUCTION |
Transcription initiation by RNA polymerase II involves the
assembly of a functional preinitiation complex on the core promoter (1). An essential step in this assembly is the recognition of
the core promoter by general transcription factors. The
TBP1 subunit of TFIID plays a
crucial role in this recognition event for TATA-containing promoters
(2). For promoters that do not contain canonical TATA sequences
(referred as TATA-less), other factors probably contribute to the
correct positioning of the polymerase. Biochemical analyses indicate
that the TafII subunits of TFIID make extensive contacts to
the core promoter independently of the TATA element (3). This has
implicated TafIIs themselves in participating in the core
promoter recognition event and has suggested that TafIIs
might be particularly important for recognition of TATA-less core
promoters. In any event, this would define the general transcription
factor TFIID as being the key player in core promoter recognition.
However, the role and mechanisms of action of the TafIIs
still remain unclear. Recently TafII-containing complexes
distinct from TFIID have been described in mammalian cells and in yeast (4-7). These complexes share some but not all TFIID TafII
subunits. One example is the yeast SAGA histone acetyltransferase
complex. These findings might call into question the presence of TFIID at all promoters. It could be that other TafII-containing
complexes function at some promoters. Such a possibility has been
further supported by studies of the in vivo role of many
TafIIs in yeast (for reviews, see Refs. 8 and 9). Indeed,
it appears that some TafIIs may be generally required for
transcription (such as yTaf17IIp), whereas others function
only at some core promoters (such as yTaf145IIp).
To understand in detail the mechanism of transcription initiation at
TATA-less promoters, in vitro studies have not been very useful, because transcription initiation from promoters that lack both
a TATA box and an initiator sequence is usually inefficient. In yeast,
the HIS3 gene has been used as a model to investigate the
differences between TATA-containing and TATA-less core promoter transcription initiation. Indeed, the HIS3 promoter contains
both types of core promoters, which are functionally distinguishable (10, 11), because activation by upstream bound activators only
functions through the TATA promoter. In TafII depletion
assays, transcription from the HIS3 TATA-less promoter has
been shown to decrease preferentially in some cases. This has led to
the suggestion that yTafII19p, yTafII145p,
yTafII40p, and yTafII67p are more specifically
required for TATA-less transcription (12, 13). In contrast, recent work
has suggested that in fact yTafII40p is generally required
for transcription by RNA polymerase II (14). yTafII40p and
yTafII19p are the yeast homologues of
huTafII28p and huTafII18p, two subunits of the
human TFIID complex interacting via histone-fold dimerization domains
(15). yTafII145p is the yeast homologue of
huTafII250 and was presumed to be the TFIID scaffold,
although this belief has been challenged by recent work (discussed in
Ref. 9). Not much has been described about yTafII67p.
In other studies, the five NOT genes have been identified by
mutations that increase HIS3 transcription. The Not proteins preferentially repress transcription from the HIS3 TATA-less
promoter and have been described as global regulators of transcription, as they also affect the transcription of many unrelated genes (16-18).
The Not proteins are associated in one or multiple large complexes (16)
that also contain the Ccr4 and Caf1 proteins, known to be required for
nonfermentative gene expression (19). It has been suggested that the
Ccr4-Not complex might function to repress transcription of TATA-less
promoters by sequestering or inhibiting factors more specifically
required for TATA-less transcription (18). A putative target of the
Ccr4-Not complex is TFIID (or some of its subunits) because of its
probable implication in core promoter recognition. At the present time,
there is no experimental evidence to support this model. Not1p has been
reported to co-immunoprecipitate with TBP (20), but other experiments have shown that transcriptional activity resulting from a functional Spt3p-TBP interaction is a target for repression by the Not1p (21).
Furthermore, interactions between Not2p and the Ada proteins have also
been reported (22). Taken together, these results might point to the
SAGA complex rather than TFIID.
To further understand the mechanisms involved in transcription
regulation by the Ccr4-Not complex, we sought to investigate whether
yTafII19p, a TFIID subunit apparently preferentially
required for transcription of the HIS3 TATA-less promoter,
interacted in any way with the Ccr4-Not complex. Our interest in
yTafII19p in particular was raised partly from the
observations that (i) Spt3p and yTafII19p carry homologous
sequences (15) and are thought to play similar roles in the SAGA and
TFIID complexes, respectively (discussed in Ref. 9), and (ii) Spt3p
appears to be a target for transcriptional regulation by the
Ccr4-Not complex (21). We isolated temperature-sensitive
taf19 alleles and found that they displayed, at permissive
temperature, striking synthetic slow growth phenotypes with
not4 and not5 mutants on minimal medium. In
particular, two not5 alleles encoding truncated proteins of different lengths behaved differently when combined with mutant taf19 alleles but not with wild type TAF19. This
suggested that yTafII19p and Not5p might interact, a
hypothesis that could be confirmed both by two-hybrid experiments and
by a direct interaction between Not5p and yTafII19p
in vitro. Our results provide the first evidence that
adequate transcription regulation by the Ccr4-Not complex may involve
interactions with TFIID TafIIs.
 |
EXPERIMENTAL PROCEDURES |
Strains and Media--
All strains are described in Table
I and were generated by classical genetic
techniques. Media were standard. Strains carrying the kanMX4 module
were selected for on YPD plates supplemented with G418 (200 mg/l, Life
Technologies). Escherichia coli DH5
and BL21 (DE3) were
used as cloning host and for recombinant protein expression,
respectively.
TAF19 Gene Disruption--
TAF19 complete disruption
was obtained through homologous recombination by transformation of
PCR1-synthesized marker
cassettes with long flanking homology regions into MY542 (23). Briefly,
by using two consecutive PCRs, upstream and downstream regions of
TAF19 (containing start and stop codons, respectively) were
placed at each end of the selectable kanMX4 cassette from pFA6a-kanMX4.
The primers used for the TAF19 long flanking homology-PCR
synthesis were as follows: P5', 5'-AAA AGT CGA CTC CTC TGC ACG TCC AAC ACC C-3' (the HincII site is
underlined; the region starting 304 base pair upstream of the
TAF19 start codon is in boldface); P5'L, 5'-GGG GAT CCG TCG
ACC TGC AGC GTA CGC ATA TCT TAT CCA GCT
CAC CC-3' (the reverse complement of the TAF19 start
codon is in boldface and underlined; the TAF19 5' upstream
region is in boldface; and the kanMX4 region is in plain text); P3'L,
5'-AAA CGA GCT CGA ATT CAT CGA TGA TAT GAT ATA GCT ACT TGG CAG GC-3' (the TAF19 stop codon is in
boldface and underlined; the TAF19 3' downstream region is
in boldface; and the kanMX4 region is in plain text); and P3', AAA
ACT GCA GTA GGA GGC GCA CGT ACC TTC C (the
PstI site is underlined; the region starting 398 base pair
downstream of the TAF19 stop codon is in boldface). Correct
integrations were verified by PCR by using P5', P3', and KanMX4
internal primers.
Plasmids--
pMAC195 is a URA3 centromeric plasmid
that expresses a fully functional full-length yTafII19p
from the DED1 promoter. pMAC186 is a pUCBM21 derivative
carrying the TAF19 ORF cloned in the vector EcoRV-SacI sites. pML25 is a derivative of the
pPC86 plasmid (24) containing the TAF19 ORF cloned between
the promoter and 3' untranslated sequences of ADC1. pMAC197
is a pET15b derivative carrying the TAF19 sequences. It was
created by the cloning of the EcoRV-BamHI fragment of pMAC186 into pET15b. The TAF19 sequences of
pML25 were replaced with the taf19-1, taf19-7,
and taf19-9 mutant sequences, leading to pML64, pML65, and
pML66. pML98 is a pLex202 derivative (25) that encodes the
LexA-yTafII19 fusion protein from the ADC1
promoter. pML135, pML132, and pML133 are the same fusion to the mutant
yTafII19p proteins. pML69, pML70, and pML71 are pPC62 (24)
derivatives expressing yTafII19p, yTafII19-1p,
and yTafII19-9p from the ADC1 promoter. pML63
carries a GST-TAF19 fusion cloned under the control of the
arabinose-inducible E. coli AraC promoter. pML136 was
generated by cloning a Xba-HindIII fragment encoding a
tagged version of yTafII40p from pRS415-TAF40 (26) into pRS424.
pMAC253 is a pET15b derivative that carries a 1.6-kilobase pair
HindIII-BamHI fragment of CCR4,
starting 472 nucleotides downstream of the ATG, thus expressing a
truncated protein.
pMPM272 encodes GST from the arabinose-inducible E. coli
AraC promoter (kindly provided by Mathias Mayer).
pU61 is a pET22b/pET15b derivative encoding a His6-Not5
fusion protein (the fusion is at the N terminus of Not5p). A stop codon
and 3' untranslated NOT5 sequences separate the
NOT5 ORF and the pET22b His6 sequences. Plasmids
are summarized in Table II.
Cloning details are available upon request.
Isolation of taf19 Mutant Alleles--
pMAC186 was used as DNA
template for TAF19 PCR mutagenesis by using the classical
forward and reverse primers and the Taq polymerase (Life
Technologies, Inc.). PCR products were pooled and cloned in pML25 to
replace the TAF19 wild type allele. We obtained a library of
11 × 103 independent transformants that was
transformed into MLY187.
Analysis of Transcript and Proteins Levels in TAF19 and taf19-1
Strains--
After dilution from an overnight culture in rich medium,
wild type and mutant cells were grown in rich medium to an
A600 of 0.3 at 30 °C. The cultures were then
shifted to 37 °C. At each time point indicated thereafter, total
cellular RNA from the equivalent of 10 A600 of
cells was extracted and analyzed by S1 nuclease protection assay as
previously published (18, 27). The oligonucleotide for NOT5
mRNA analysis was 5'-GCG AGG CTG ATT CTA CAC CTG GCG CGA TTG GAG
TCG TCG CCC TGT CTG ATA TAG AAA CAT CCC AAC AAC AA-3'. In parallel,
equal amounts of cells (equivalent to 1 unit of
A600) were harvested by rapid
centrifugation and washed with cold water, and total proteins were
extracted according to Ref. 28. For this procedure, the frozen
cell pellet was thawed on ice in 150 µl of lysis buffer (1.85 M NaOH, 7.4%
-mercaptoethanol), vortexed, and left 10 min on ice. Proteins were then trichloroacetic acid-precipitated by the addition of 150 µl of trichloroacetic acid 50% and
resuspended in 80 µl of SDS-PAGE sample buffer (40 µl of 0.1 M NaOH and 40 µl of 2× sample buffer). Equal amounts of
total cell extracts (10 µl) were then fractionated by SDS-PAGE and
analyzed by Western blot using chemiluminescence (Pierce). Antibodies
against yTafIIs and TBP were kindly provided by Joe Reese
and Anthony Weil. Antibodies against Not1p and Not5p were described
previously (16, 21). Antibodies against yTafII19p and Ccr4p
were raised. Briefly, recombinant yTafII19p was expressed
from pMAC197, and recombinant Ccr4p was expressed from pMAC253, in
BL21. The recombinant proteins were purified according to standard
protocols (Qiagen) and were injected into rabbits (Elevage Scientifique
des Dombes). Antibodies to yTafII19p were used at 1:3000,
and those to Ccr4p were used at 1:8000.
Two-hybrid Interactions--
To test protein-protein
interactions, pLex202 derivatives were cotransformed into EGY48 (25)
with pJG4-5 derivatives encoding galactose-inducible B42 fusions to
Not proteins (16, 18), as well as to Ccr4p and Caf1p (19).
Protein-protein interactions were scored as function of growth on
synthetic galactose but not glucose minimal medium lacking leucine.
-Galactosidase Assays--
Strains carrying the fusion
proteins to be tested were grown overnight in 1 ml of glucose minimal
medium supplemented with leucine. The cells were washed twice in water
and resuspended in 10 ml of galactose minimal medium supplemented with
leucine. After 24 h, the cultures were collected, and
-galactosidase assays performed as described previously (17).
GST Pull-down Analysis--
Unless otherwise stated, protein
manipulations were performed at 4 °C. E. coli BL21(DE3)
was transformed either with pMPM272 (encoding GST), pML63 (encoding
GST-yTafII19p), or pU61 (encoding His6-Not5p).
Transformed cells were grown at 30 °C to an
A600 of 0.6 in 100 ml of rich medium containing
ampicillin (100 µg/ml), and recombinant proteins were induced by
addition of arabinose (final concentration, 0.5% in the case of GST
and GST-yTafII19p) or
isopropyl-1-thio-
-D-galactopyranoside (final
concentration, 0.5 mM for His6-Not5p). Cells
were allowed to grow at 37 °C for 4 h, harvested, washed with
cold water, resuspended in 5 ml of Buffer A (50 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM
-mercaptoethanol, 1 mM phenylmethylsulfonyl
fluoride) supplemented with RNase A and DNase I (0.1 mg/ml,
Sigma), and broken by sonication. Cellular debris and aggregates were
discarded by centrifugation (20 min at 40,000 × g),
and supernatants were supplemented with glycerol (final
concentration, 10%) and kept frozen until used. Equal total protein
amounts (200 µg) of His6-Not5p extract were mixed
with GST extract, GST-yTafII19p extract, or Buffer A, and
the volume was brought to 100 µl with Buffer A and Tween 20 (final
concentration, 0.1%), making Buffer B. The concentration of
His6-Not5p and GST-yTafII19p in these extracts
was roughly similar, with perhaps a 3-fold higher level of the former,
as determined by Coomassie staining. Tubes were incubated at
30 °C for 2 h. Reactions were centrifuged for 20 min at
40,000 × g, and 25 µl of a 50% gel slurry of
glutathione-Sepharose beads (Amersham Pharmacia Biotech),
previously equilibrated with Buffer B, was added to each supernatant.
Suspensions were incubated at 30 °C for 1 h with a mild
agitation and then centrifuged at 2000 × g for 1 min.
Supernatant was kept on ice (fraction S), and beads were washed three
times with 100 µl of cold Buffer B. The third wash was kept on ice
(fraction W), and beads were resuspended with 100 µl of SDS-PAGE
loading buffer (fraction B). Equal amounts (10 µl) of fractions S, W,
and B were analyzed by Western blotting using antibodies directed
against Not5p.
Yeast Extract Preparation--
For preparation of total cell
extracts 12 liters of cells grown to an A600 of
4.5 were pelleted and washed, and the pellet was frozen at
80 °C.
This pellet was then slowly thawed and resuspended in 100 ml of lysis
buffer (29), including 1 mM dithiothreitol and protease
inhibitors. We additionally added a tip of DNase I (Sigma). Cells were
broken in the cold with a French press (SLM AMINCO 20K Cell FA-073)
three times at 1500 p.s.i. Then, the suspension was clarified
first by 20 min at 16,000 × g and 1 h at 35000 rpm in a Beckman Ti35 ultracentrifuge.
For fractionation by ammonium sulfate precipitation, first 109 g/liter
were added to the extract resulting in 30% ammonium sulfate. The
precipitate was removed by ultracentrifugation (1 h centrifugation at
35,000 rpm in a Ti35 rotor) and 86 g/liter were then added to the
supernatant leading to a 45% ammonium sulfate solution. The
precipitate was collected by the same ultracentrifugation procedure,
and 59 g/liter were added to the supernatant leading to 55%
ammonium sulfate concentration. Finally, after collecting the
precipitate the same way, 93 g/liter were added to the supernatant, leading to 70% ammonium sulfate. The pellets were resuspended in the
minimal amount of lysis buffer carrying additionally 0.1% Nonidet P-40
and then dialyzed against 100 volumes of the same buffer. 300 µl of
the dialyzed 45% cut of the cell extract was then analyzed by gel
filtration (see below).
Gel Filtration Analysis--
For gel filtration analysis, 300 µl of total cell extracts were loaded on a Superose 6 gel filtration
column equilibrated with 350 mM NaCl, 10% glycerol, 0.1%
Tween 20, and 40 mM Hepes, pH 7.3. The column was run at
0.4 ml/min, and 400 µl fractions were collected starting at 16 min
and analyzed by Western blot analysis for the presence of
yTafII19p (10-15% Tris Tricine gel). The position
of the void volume was determined by the elution of salmon sperm DNA.
 |
RESULTS |
Isolation of Conditional Alleles of TAF19--
We have suggested
that the Ccr4-Not complex regulates transcription by sequestering or
inhibiting transcription factors more specifically required for TBP
function at TATA-less promoters. A potential candidate for such a
factor is yTafII19p. To start investigating whether
yTafII19p is associated with Ccr4-Not function, we used a
genetic approach and first created a library of mutant TAF19
alleles. TAF19 was mutagenized by error-prone PCR
amplification of TAF19, and the library of mutant alleles
was cloned into a yeast TRP1 centromeric plasmid (pML25).
This library was transformed into MLY187, a yeast strain carrying a
complete disruption of the genomic TAF19 gene complemented
by pMAC195, a URA3 centromeric plasmid carrying a wild type
copy of TAF19. Transformants were streaked on 5-fluoroorotic
acid to select for the loss of the episomal wild type copy of the
TAF19 gene. The 5-fluoroorotic acid-resistant transformants
were streaked on rich medium at 16, 30 and 37 °C to determine
whether conditional mutants had been isolated.
Out of this screen, we further characterized three taf19
mutants, called 19-1, 19-7, and19-9.
taf19-7 grew slowly on rich medium and at all temperatures,
whereas the other two mutants grew well on rich medium at 30 °C but
were temperature-sensitive (Fig.
1A). These phenotypes were
recessive. The mutant alleles were sequenced. taf19-1
carries four mutations that result in four amino acid changes (D46G,
L63H, L79D, and K98M), taf19-9 also carries four mutations
that result in four amino acid changes (D24G, E38G, N57D, and F70S),
and finally, taf19-7 is a point mutant that results in a
single amino acid change (K13E). Fig. 1B shows the position
of these mutations within the yTafI119p.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 1.
Characterization of taf19
mutant alleles. A, growth of wild type and
mutant taf19 strains. Two temperature-sensitive
mutants (taf19-1 and taf19-9) and one sick mutant
(taf19-7) were isolated and streaked together with the
isogenic wild type TAF19 strain on YPD plates at 30 and 37 °C as indicated. Strains used were MLY268 (TAF19),
MLY270 (taf19-1), MLY272 (taf19-7), and
MLY274 (taf19-9). B, schematic structure of
yTafII19p with the position of amino acid
substitutions in the mutant yTafII19 proteins. This scheme
is based on the alignment in Ref. 15. C, growth curve of
wild type or taf19 mutants at 37 °C. MLY268, MLY270, and
MLY274 were grown in YPD at 30 °C to an A600
of 0.3, and the cultures were then shifted to 37 °C. In parallel,
cultures that were kept at 30 °C grew similarly, independently of
the TAF19 allele (data not shown).
|
|
Because taf19-1and taf19-9 carry multiple
mutations, we tried to determine whether any individual mutation was
responsible for the temperature-sensitive phenotype. Many of these
mutations lie in the domain of yTafII19p that is thought to
be involved in dimerization with yTafII40p (15).
Particularly, residue Asp-24 is conserved between
yTafI119p and orthologs from human, Drosophila, and Caenorhabditis elegans. In the three-dimensional
structure (huTafII18-huTafII28 heterodimer
structure), the huTafII18p Asp-45 residue (corresponding to
yTafII19p Asp-24) is involved in a strong hydrogen bond
network that stabilizes the heterodimer. On the other hand, this
heterodimer is also stabilized by multiple hydrophobic interactions
occurring at the crossover of two
-helices (in
huTafII18p, residues 60-70 of the
2-helix). A mutation
lying in this area (yTafII19p Asp-46 corresponds to
huTafII18p Glu-67) might induce a local disorganization of
the
2-helix, resulting in the destabilization of the heterodimer.
Surprisingly, in the case of taf19-1, neither D46G alone nor
an allele carrying the other three mutations (L63H, L79D, and K98M)
conferred a temperature-sensitive phenotype (data not shown). Thus,
temperature sensitivity is conferred by D46G and at least one other
mutation. Similarly, in the case of taf19-9, D24G alone does
not confer temperature sensitivity. However, temperature sensitivity
might still result from a disruption of this dimerization domain,
which in turn might require more than one mutation. This hypothesis was confirmed by the fact that overexpressing
TAF40 (from plasmid pML136) suppressed the temperature
sensitivity of taf19-1 and taf19-9
(MY2268-MY2271; see Table I) at 36 °C (data not shown). In this
context, it is interesting to note that temperature-sensitive taf40 alleles were also found to carry multiple mutations
within the equivalent yTafII40p dimerization domain and
that this temperature-sensitive phenotype was also alleviated by
overexpressing yTafII19 (14).
Phenotypic Analysis of the taf19-1 and taf19-9 Mutants--
Not
much is known about TAF19. We thus first further
characterized the two conditional alleles that we had isolated, namely taf19-1 and taf19-9. Fig. 1C shows
that both mutants rapidly arrest cell growth as the cells are shifted
to the restrictive temperature. Viability of the taf19
mutants was assayed at given times after the temperature shift and was
found to be very weakly affected only after 6 h at the restrictive
temperature (data not shown).
Our interest in isolating taf19 mutant alleles was based
upon a previous description of the preferential loss of transcription from TATA-less promoters upon yTafII19p depletion (12).
However, similar results were described with yTafII40p,
yet, as mentioned above, more recently, yTafII40p has been
said to be generally required for transcription (14). To determine what
phenotype our conditional mutants displayed at restrictive temperature
upon loss of yTafII19p function, total cellular RNA was
extracted from wild type and taf19-1 cells just prior to the
shift to the restrictive temperature and at given times after the
shift. This RNA was analyzed by S1 mapping first for the levels of the
DED1 transcript expressed from a TATA-containing promoter,
and the NOT5 and HIS4 transcripts that do not
depend upon a canonical TATA sequence. It should be clarified that we
claim that NOT5 has no canonical TATA based on the sequence
of the promoter region. In the case of HIS4, this has been
previously reported (30). In taf19-1 cells, within 4 h
after the shift, the levels of the HIS4 and NOT5
transcripts decreased to a nondetectable level, whereas the level of
the DED1 transcript remained stable (Fig.
2A). At later time points (6 h), the DED1 transcript also decreased (data not shown).
Because the HIS4 and DED1 transcripts have been
described to have similar half-lives (27), this result suggests that
HIS4 transcription is more rapidly affected than
DED1 transcription. Because we realized that the
taf19 mutants isolated grew slowly on minimal medium lacking
threonine or isoleucine, we also investigated the ILV1 transcript levels in wild type and mutant cells shifted to the restrictive temperature for 4 h, because the ILV1 gene
lies in the pathway of the biosynthesis of both amino acids. This
mRNA has been reported to be transcribed from a TATA-less
promoter (31), and it was also dramatically decreased 2 h after
the shift to the restrictive temperature (Fig.
2B). We then similarly analyzed the levels of an unstable
tRNA (27) and found that transcription by RNA polymerase III was not
measurably affected in either strain (Fig. 2B). Finally, we
looked at HIS3 transcript levels and found that whereas
transcription of HIS3 from both promoters decreased upon
inactivation of yTafII19p, that from the TATA-less promoter decreased more rapidly and more severely (Fig. 2C, compare
lane 4 to lane 1). Taken together these results
suggest that the loss of yTafII19p function affects more
rapidly transcription from the TATA-less promoters (HIS3,
HIS4, NOT5, and ILV1) than from the
canonical TATA-containing promoters (HIS3 and
DED1).

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 2.
TAF19 may generally affect transcription, but
it is preferentially required for transcription from TATA-less
promoters. A, MLY268 and MLY270 were grown in YPD at
30 °C to an A600 of 0.3, and cultures were
then shifted to 37 °C. Total RNA was extracted from TAF19
and taf19-1 strains at the indicated time points after
shifting to 37 °C. 50 µg of total RNA were analyzed by S1 nuclease
protection assay for the levels of the indicated transcripts.
Transcription of HIS4 depends upon a TATA-less core promoter
in gcn4 strains (30), and sequence analysis shows that
the NOT5 promoter does not contain a canonical TATA
sequence. In contrast the DED1 promoter carries a canonical
TATA sequence. The hybridizations were internally controlled by
simultaneous hybridization of NOT5 and HIS4 with
DED1. Similar results were obtained with the
taf19-9 temperature-sensitive mutant (data not shown).
B, the same experiment was performed, and the total cellular
RNA was hybridized to measure the levels of ILV1 and
WtRNA. The ILV1 is also thought to
carry a TATA-less promoter. C, the same experiment was
performed with strain MLY270 alone, and total cellular RNA was
hybridized to measure the levels of the HIS3 and
DED1 transcripts.
|
|
Decreased Steady State Level of TFIID Components upon
yTafII19p Inactivation--
It has not been demonstrated
that yTafII19p is definitively part of TFIID. It is thought
to be, by homology with its human counterpart (15) and because it
co-immunoprecipitates with both yTafII145p and TBP (12).
Because it has been reported that depletion of given
yTafIIs leads to degradation of other yTafIIs
that are part of the same complex, we investigated whether inactivation of yTafII19p similarly affected the steady state levels of
other yTafIIs. Total protein extracts were prepared in
parallel to the RNA mentioned above, and they were analyzed by Western
blot for the levels of different yTafIIs. As shown on Fig.
3, in taf19-1 mutant cells,
the levels of specific TFIID yTafIIs
(yTafII145p and yTafII40p) rapidly decreased
upon inactivation of yTafII19p. The levels of other
yTafIIs, shared between the TFIID and SAGA complexes, such
as yTafII60p, yTafII68p, and
yTafII90p, or even with the SWI/SNF complex, such as
yTafII30p, decreased somewhat slower or were unaltered
after 4 h at the restrictive temperature. TBP levels decreased
rapidly to a lower stable level. The levels of yTafII19p
itself were undetectable in up to 100 µg of total cell extract with
the antibodies that we raised.

View larger version (65K):
[in this window]
[in a new window]
|
Fig. 3.
Decreased steady state levels of
yTafIIs, TBP, and Ccr4-Not complex subunits upon
inactivation of TAF19. MLY268 (TAF19)
and MLY270 (taf19-1) were grown in YPD at 30 °C to an
A600 of 0.3, and cultures were then shifted to
37 °C. At different time points (as indicated) after the shift at
37 °C, total proteins were extracted from equal amounts of cells
(see under "Experimental Procedures"). Protein extracts from equal
amounts of cells were then fractionated by SDS-PAGE and blotted to
nitrocellulose. The levels of different TFIID and Ccr4-Not complex
subunits (as indicated) were analyzed by Western blot.
|
|
These results are very similar to what has been described previously
for temperature-sensitive taf40 mutants (14) and support the
presence of yTafII19p in TFIID. They also suggest that the inactivation of yTafII19p leads to the destabilization of
TFIID through the degradation of some specific TFIID TafIIs
(e.g. yTafII40p and yTafII145p).
Moreover, yTafII25p, a yTafII shared by TFIID and SAGA, was rapidly decreased upon yTafII19p
inactivation. In that context, it is interesting to note that upon
yTafII25p inactivation, yTafII19p was also
rapidly degraded (32).
We also investigated the levels of some of the components of the
Ccr4-Not complex. All of the components that were analyzed, namely
Not1p, Not5p, and Ccr4p, also decreased, but not as dramatically, nor
as quickly, as the yTafIIs. Because, at least in the case of NOT5, we have found that transcription is affected by the
loss of yTafII19p, the decrease in Not5p may be a
consequence of protein turnover. In any event, it is important to note
that the levels of the different Ccr4-Not components were similar in
the wild type and mutant strains at the permissive temperature.
taf19 Mutants Display Synthetic Phenotypes with Specific not
Mutants--
We next used a genetic approach to determine whether the
function of yTafII19p was related to that of the Ccr4-Not
complex. We constructed a large number of double mutants by
crossing taf19-1 and taf19-9 to many
ccr4-not mutants, sporulating diploids and dissecting
tetrads. The phenotypes of the double mutants were compared with the
phenotypes of the single mutants to look for synthetic lethal
interactions or suppression. In particular, growth on rich medium at
16, 30, and 37 °C as well as growth on minimal medium at permissive
temperature was analyzed. not1-1, not1-2, not2-1, not2-4, not3::URA3,
caf1::LEU2, and ccr4::URA3
mutants did not show any obvious genetic interaction with
taf19-1 or taf19-9. In contrast, not4
and not5 mutants did. not4-1, but more
dramatically not4::LEU2, showed a synthetic
phenotype when combined with both taf19-1 and
taf19-9 on minimal medium at 30 °C (Fig.
4). This same effect was observed when
the minimal medium was complemented with histidine (data not shown). A
slight synthetic growth phenotype could also be detected on rich medium
at 30 °C (not shown). More interestingly,
not5::LEU2 and not5-1, but not
not5-2, displayed a dramatic synthetic growth phenotype on
minimal medium when combined with either one of the two
taf19 mutants (Fig. 4). The two alleles, not5-1
and not5-2, are similar in that they both carry nonsense mutations (16), but they can be distinguished by the fact that the
protein encoded by not5-1 is shorter (see Fig. 4,
bottom). Such an allele-specific synthetic phenotype
strongly supports the fact that yTafII19p and Not5p
functionally interact for growth on minimal medium and may even be
physically associated. Alternatively, yTafII19p and the
Ccr4-Not complex may participate independently in transcriptional
regulation required for growth on minimal medium, and the contribution
of the Ccr4-Not complex may be only seriously impaired when Not4p is
absent or when Not5p is sufficiently truncated.

View larger version (103K):
[in this window]
[in a new window]
|
Fig. 4.
Synthetic slow growth of double
taf19 and not4 or not5
mutants on minimal medium. Double mutants, isogenic single
mutants and wild type strains were streaked together on minimal plates
lacking histidine at 30 °C. Strains used were MLY268
(TAF19), MLY270 (taf19-1), MLY274
(taf19-9), YOU584 (not4 ), MLY365
(not4 taf19 + TAF19), MLY367
(not4 taf19 + taf19-1), MLY369
(not4 taf19 + taf19-9), MY1719
(not5 ), MLY329 (not5 taf19 + TAF19), MLY331 (not5 taf19 + taf19-1), MLY333 (not5 taf19 + taf19-9), YOU123 (not5-1), MLY347 (not5-1
taf19 + TAF19), MLY349 (not5-1 taf19 + taf19-1), MLY351 (not5-1 taf19 + taf19-9), YOU142 (not5-2), MLY353 (not5-2
taf19 + TAF19), MLY355 (not5-2 taf19 + taf19-1), and MLY357 (not5-2 taf19 + taf19-9). At the bottom of the figure are shown schemes
of the Not5 wild type and mutant proteins. The growth of the various
strains was no different when the plates were supplemented with
histidine (data not shown).
|
|
TAF19 Interacts by Two-hybrid with NOT5--
To investigate
further whether or not yTafII19p and Not5p may interact, we
performed a two-hybrid analysis. A plasmid expressing a
LexA-yTafII19 fusion protein was constructed (pML98, see
under "Experimental Procedures") and found to complement a null
mutation of TAF19. It was transformed into a strain carrying
a leu2 gene under the control of LexA operators (EGY48; see
Table I). Additional plasmids were co-transformed that expressed
fusions of all the known components of the Ccr4-Not complex to the
B42-activation domain (16, 18) under the control of the GAL1
promoter. Growth on glucose or galactose plates devoid of leucine was
investigated. Fig. 5 shows that a
positive two-hybrid interaction could be detected among
TAF19 and NOT5, NOT3, NOT2, and
CAF1 (the latter two to a lesser extent). Growth of
all of these strains on galactose minimal medium supplemented with
leucine was compared and found to be indistinguishable, except that the
strains carrying B42-NOT2 and B42-NOT3 grew
somewhat more slowly (data not shown). To confirm these results, the
expression of
-galactosidase was measured in the same strains after
growth for 24 h in liquid galactose minimal medium supplemented
with leucine. Table III summarizes these
results. With this second reporter, an interaction between yTafII19p and Not2p, Not3p, and Not5p is confirmed, and an
interaction between yTafII19p and Ccr4p is additionally
detectable. No interaction can be measured between
yTafII19p and Caf1p with this second reporter. Finally, no
interaction between Not1p or Not4p and yTafII19p was detectable with either of the two reporters. These results support the
existence of a physical interaction between yTafII19p and components of the Ccr4-Not complex, in particular Not5p, that was
suggested by the allele-specific synthetic growth phenotypes presented
above.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 5.
TAF19 interacts with NOT5 in
the two-hybrid assay. A, EGY48 was transformed with
pML98 (LexA-yTafII19p) together with pJG4-5 derivatives
expressing either the B42-Not1, B42-Not2, B42-Not3, B42-Not4, B42-Not5,
B42-Ccr4, or B42-Caf1 fusion proteins as indicated. B, EGY48
was transformed with the plasmid expressing the B42-Not5 fusion
protein, together with plasmids encoding fusion proteins of LexA to
either wild type or mutant forms of yTafII19p as indicated.
In both cases, transformants were grown overnight in synthetic glucose
medium supplemented with leucine. Cells were harvested, washed twice in
cold water, and allowed to grow for 4 h in synthetic galactose
medium supplemented with leucine. Equal amounts of cell culture (1 A600 unit) were washed with water, serially
diluted, and spotted either on YPD, glucose minimal medium
(Glu), or galactose minimal medium (Gal). The
same strains were streaked on galactose minimal medium supplemented
with leucine and grew indistinguishably, except the strains expressing
B42-Not2p and B42-Not3p that grew somewhat slower (data not
shown).
|
|
View this table:
[in this window]
[in a new window]
|
Table III
-Galactosidase assays to measure two-hybrid interactions
The indicated strains are described in Table I, and all carry the
LexA-LacZ reporter gene. All of these strains carry
LexA-TafII19p and the indicated B42 fusion protein. The values
for -galactosidase activity indicated for two separate experiments
were calculated in nmol × mg 1 min 1.
|
|
One way to investigate further whether the interaction between
yTafII19p and Not5p is functionally relevant is to
determine whether any of the taf19 mutants isolated are
defective in this interaction. We thus introduced the taf19
mutations into the construct expressing LexA-yTafII19p
(pML132, pML133, and pML135; see under "Experimental
Procedures"). Except for LexA-yTafII19-7p, all new fusion
proteins complemented the null mutation of TAF19 and were expressed at the same level as LexA-yTafII19 (data not
shown). The new fusions were tested for a two-hybrid interaction with B42-Not5p (see Fig. 5, bottom panel). No interaction
was detected between LexA-yTafII19-1p and B42-Not5p,
whereas in contrast, the LexA-yTafII19-9 protein interacted
with B42-Not5p, in a manner indistinguishable from
LexA-yTafII19p. Thus, not all taf19 mutants isolated are detectably defective in yTafII19p-Not5p
interaction, but the finding that one is, is additional support for a
functional physical association of yTafII19p and Not5p
in vivo. Indeed, yTafII19-1p and
LexA-yTafII19-1p are functional at the permissive
temperature, because they replace a wild type yTafII19p for
vegetative growth. This indicates that the proteins are correctly
folded. Hence, the absence of interaction with Not5p indicates that
mutated residues in yTafII19-1p are important for
interaction with Not5p.
yTafII19p and Not5p Associate Physically in
Vitro--
Because the two-hybrid experiments described above are
performed in vivo, they do not define whether or not
yTafII19p and Not5p can interact directly. To address such
a question, we prepared bacterial extracts from E. coli
expressing GST-yTafII19p, GST alone, or
His6-Not5p recombinant proteins to test their interaction in vitro. The expression and solubility of all proteins was
verified by analyzing the total soluble bacterial extracts by Western
blotting with antibodies to the GST moiety or to Not5p (data not
shown). Not5p was detected as multiple forms (as can be seen in S lanes of Fig. 6), most likely resulting from
protein degradation. Most of these detectable forms were capable of
binding Ni-nitrilotriacetic acid agarose (data not shown),
suggesting that they were stable C-terminal truncations.

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 6.
yTafII19p interacts directly with
Not5p in vitro. Bacterial extracts containing
His6-Not5p were mixed with bacterial extracts devoid of any
recombinant protein (left three lanes), with bacterial
extracts containing recombinant GST-yTafII19p (middle
three lanes), or with bacterial extracts containing recombinant
GST alone (right three lanes). After 2 h at 30 °C,
the reactions were incubated with glutathione-Sepharose beads.
Equivalent amounts of unbound fraction (S), the third bead
wash (W), and the bound fraction (B) were
analyzed by SDS-PAGE followed by Western blot analysis with antibodies
to Not5p. The major visible forms of His6-Not5p were all
capable of binding Ni-nitrilotriacetic acid agarose, suggesting that
they are C-terminal Not5p truncations. Only the largest forms were
found in fraction B, specifically in the case of incubation with
recombinant GST-yTafII19p, and are labeled with an
asterisk. The same results were obtained when binding was
performed with 300 mM salt and 0.5% Tween 20 and were
reproduced many times.
|
|
Bacterial extracts containing His6-Not5p were incubated
with Buffer A or with bacterial extracts containing either GST or GST-yTafII19 in the presence of 150 mM salt and
0.1% Tween 20 (see under "Experimental Procedures"), and
glutathione-Sepharose beads were then added. The beads were washed, and
then the unbound extract (Fig. 6, S), wash (W),
and beads (B) were analyzed by Western blot for the presence
of Not5p. His6-Not5p was retained on the beads specifically
in the presence of GST-yTafII19p. Interestingly, only the
three longest forms of His6-Not5p (all capable of binding Ni-nitrilotriacetic acid agarose) were retained on the beads carrying GST-yTafII19p. Similar results were obtained with higher
stringency (300 mM salt and 0.5% Tween 20) (data not
shown). These results demonstrate that yTafII19p and Not5p
can directly associate in the absence of other yeast proteins. It
appears that the interaction between yTafII19p and Not5p
requires a minimal N-terminal Not5p fragment, a finding that might
relate directly to the observation that the not5-1 allele,
but not the not5-2 allele, which encodes a longer protein,
displays synthetic growth phenotypes with taf19 mutants
in vivo.
yTafII19p Is Found in Multiple Complexes in
Vivo--
The results presented so far demonstrate allele- and
gene-specific genetic interactions between TAF19 and genes
encoding components of the Ccr4-Not complex. They further show that
yTafII19p and Not5p physically interact. These results are
in agreement with a model whereby components of the Ccr4-Not complex
might be associated with and regulate yTafII19p. Our
findings also confirm the hypothesis that yTafII19p is part
of the TFIID complex, but it is not known whether it may be part of any
other complexes, such as Ccr4-Not complexes. As mentioned above, with
the antibodies that we raised, we could not detect
yTafII19p in 100 µg of total cell extracts by Western
blot analysis. However, we could detect yTafII19p very specifically in 45 and 55% ammonium sulfate cuts of total cell extracts (Fig. 7A). In
contrast to this very specific fractionation of yTafII19p,
yTafII145p (and other yTafIIs) fractionated
with a very broad profile, from the 30% ammonium sulfate cut to the supernatant of the 70% ammonium sulfate cut (Fig. 7A). This
material enriched for yTafII19p was analyzed by Superose 6 gel filtration to determine whether yTafII19p was
associated in complexes other than TFIID. Fig. 7B shows that
the majority of yTafII19p is associated in very large
complexes. Fractionation by Sepharose 4B allowed us to clearly define
that these yTafII19p complexes of a size apparently greater
than 1 MDa were soluble complexes and not aggregated proteins (data not
shown). When equal protein amounts of each fraction were loaded on the
gel rather than equal volume equivalents of each fraction, small
amounts of yTafII19p were also detectable as eluting with a
very broad profile, as has been previously shown for
yTafII145p (33) (Fig. 7C). This shows that
yTafII19p also appears to elute in fractions 18, 22, and
26.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 7.
Most yTafII19p has a very
restricted distribution to large protein complexes. A,
total protein extracts from wild type cells were incubated with 30%
ammonium sulfate. The supernatant was brought to 45, 55, and finally
70% ammonium sulfate. The precipitates at each concentration were
resusupended and dialyzed against the extract buffer, and 50 µg of
each fraction (lanes 30C, 45C, 55C, and 70C), as
well as 50 µg of the final supernatant (lane 70S), were
analyzed by Western blot for the presence of yTafII19p and
yTafII145p as indicated. B, 300 µl of fraction
45C was analyzed by Superose 6 gel filtration. Every second fraction
was analyzed by SDS-PAGE followed by Western blot analysis with
antibodies against yTafII19p. The position of the void
volume and marker proteins of known size are indicated at the
top. The position of yTafII19p and a
cross-reactive band are indicated. Similar results were obtained with
fraction 55C. C, to reveal the possible presence of
yTafII19p in fractions other than fractions 1-4, the
protein concentration of each fraction was measured, and equivalent
amounts were similarly analyzed by Western blot for the presence of
yTafII19. The fractions displayed on the figure are the
only ones in which yTafII19 was reasonably detected (lane
numbers correspond to fraction numbers). Fraction 18 corresponds to a size of 550 kDa, fraction 22 to 350 kDa, and fraction
26 to 228 kDa.
|
|
 |
DISCUSSION |
yTafII19p is one of the less well characterized
yTafIIs so far. It is the homologue of human
TafII18p, which is known to be part of the human TFIID
complex and to form dimers with human TafII28p according to
a histone-fold type of structure (15). In yeast, TAF19 is
essential for vegetative growth, and one report has demonstrated that
not all transcription decreases similarly upon yTafII19p
depletion but that transcription from TATA-less promoters is
preferentially arrested (12). The same was reported for the yeast
homologue of human TafII28p, namely yTafII40p
(13), but a recent study claims that in fact yTafII40p is
generally required for RNA polymerase II transcription (14). In
the latter, Komarnitsky et al. show that the
temperature-sensitive phenotype of the taf40 alleles
isolated could be suppressed by overexpression of
yTafII19p, suggesting that yTafII19p should
also be generally required for transcription. We have isolated
temperature-sensitive taf19 alleles. By analyzing the levels
of transcripts of similar half lives (27), we found that not all
transcription decreases with similar rapidity upon loss of
yTafII19p function, supporting the selective requirement
for yTafII19p function previously published (12). We did
find that within 6 h of yTafII19p inactivation, all
RNA polymerase II transcripts measured decreased. However, this general
late effect could clearly be indirect, especially if one considers that
yTafII19p is needed for the stability of one or more
transcription complexes (e.g. TFIID). In fact, this late
effect also correlates with the appearance of a drop in viability. All
conditional alleles of TAF19 that we isolated carry multiple mutations, similarly to the taf40 temperature-sensitive
alleles that were isolated (14). Most of these mutations also lie in the region of TAF19 that encodes the domain of
yTafII19p thought to interact with yTafII40p.
Our analysis demonstrated that multiple mutations are necessary to
confer a temperature-sensitive phenotype. This might suggest that
multiple mutations are necessary to disrupt a
yTafII19p-yTafII40 interaction.
Alternatively, temperature sensitivity might require the loss of
yTafII19p interaction with multiple proteins. Because
overexpression of TAF40 suppresses temperature sensitivity
of the mutant taf19 alleles, the former seems a more likely explanation.
By the two-hybrid assay and GST pull-down analysis, we have
demonstrated that yTafII19p can interact with Not5p, both
in vitro and in vivo. This interaction is direct
and does not require any other yeast protein. Interestingly, one of the
taf19 mutants isolated, namely that encoding
yTafII19-1p, was no longer able to interact with Not5p in
the two-hybrid assay, even at 30 °C. At the permissive temperature
and on rich media, the strain MLY270 (taf19-1) grew as well
as the wild type, suggesting that the mutant protein is functional and
has a global unaltered conformation. Hence, the fact that
yTafII19-1p does not interact with Not5p indicates that one
(or some, if not all) of the mutated residues is directly involved in
this interaction and may define the yTafII19p domain interacting with Not5p. Within Not5p, we did not precisely localize the
domain responsible for interaction with yTafII19p, but we could show that it was in the N terminus of the protein. In this most
N-terminal part of Not5p, the first 207 amino acids are highly conserved in Not3p (40% identity), and we also detected a
yTafII19p-Not3p interaction in our two-hybrid assay.
Despite the fact that we did not try to confirm this interaction by GST
pull-down analysis, it is tempting to suggest that this conserved
domain might be the yTafII19p target. We are currently
testing this hypothesis. The yTafII19p human homologue is
quite well characterized, and complexes containing this
TafII have been isolated (15). On the other hand, human
homologues of the yeast genes encoding Ccr4-Not complex subunits have
been isolated (34). Our study thus provides us with a tool to expand
the comprehension of TafII function in the mammalian
system, and it will be very interesting to determine whether
the yTafII19p-Not5p interaction is also conserved in human.
Characterization of the level of components of the TFIID complex upon
loss of yTafII19p function at the restrictive temperature demonstrates that, similarly to what has been reported for the depletion of other TafIIs, the steady-state level of a
number of TafIIs specific to TFIID (yTafII40p
and yTafII145p) decreases to undetectable levels very
rapidly. The level of TBP also rapidly decreases to a lower level. In
fact, we show that loss of yTafII19p has effects very
similar to those of the depletion of yTafII40p, as
described previously (14). Taken together with the fact that overexpression of TAF40 suppresses the mutant
taf19 alleles that we isolated and with the fact that
yTafII19p can coimmunoprecipitate with TBP and
yTafII145p (12), these results support the idea that, like
yTafII40p, yTafII19p is part of TFIID. Further
support comes from our finding that yTafII40p and
yTafII145p, so far only described in TFIID and not in SAGA,
co-purified with GST-yTafII19p (data not shown).
It is not known how many different yTafII19p-containing
complexes may exist. We have found that most of the
yTafII19p from total cell extracts fractionates with a size
greater than 1 MDa, as determined both by Superose 6 and Sepharose 4B
gel filtration. One can also detect some yTafII19p in three
separate peaks, one of which corresponds to a size that could be TFIID
(fraction 18). Although the steady-state level of some
yTafIIs (yTafII60p, yTafII68p, and
yTafII90p) present in TFIID and SAGA remained relatively
stable upon yTafII19p inactivation, that of
yTafII25p (also found in both complexes) rapidly decreased.
Conversely, yTafII19p disappears rapidly upon
yTafII25p depletion (32). Thus, our results do not exclude
the possible presence of yTafII19p in SAGA. In this regard,
we have found that the taf19 alleles that we isolated are
synthetic lethal with the null allele of SPT3 (data not
shown). Spt3p contains histone-fold domains homologous to both those of yTafII19p and yTafII40p, and a model structure
for Spt3p in which these two domains interact has been proposed (15).
Nevertheless, one cannot exclude that yTafII19p interacts
with the yTafII40-homologous histone-fold domain of Spt3p
and thus may be present in the SAGA complex. This could account for the
synthetic lethality mentioned above. Alternatively,
yTafII19p is not in SAGA, and the taf19-spt3 synthetic lethality could be explained by the combined impairment of
TFIID and SAGA function (or of yet other TafII-containing
complexes). Further studies will be needed to elucidate this ambiguity.
Whether or not yTafII19p is in SAGA as well as in TFIID
(and maybe in other complexes), it appears that the mutant phenotype of
the alleles that we isolated can be suppressed by increasing
yTafII40p levels. Thus, the interaction with the Ccr4-Not
complex that is suggested by the genetic interactions that we described
probably involves complexes that carry both yTafII19p and
yTafII40p. This would argue in favor of TFIID or another
complex, but not SAGA.
The question of whether yTafII19p is associated in large
Ccr4-Not complexes or only interacts transiently with components of the
complex will require more work. Our findings clearly demonstrate that
yTafII19p can associate with Not5p directly, and interacts with at least four other components of the complex by the two hybrid
assay. Surprisingly Not4p is not one of these, yet not4 mutants display genetic interactions with the taf19 mutants.
However, we know that the absence of Not4p dramatically decreases the
association of Not5p in large Ccr4-Not
complexes.2
Our present results are consistent with there being a functional
interaction between the Ccr4-Not complex and TFIID, as has been
previously suggested. Indeed, one can imagine that there is an
equilibrium between the different yTafII19p and Not5p
complexes. What elements regulate this balance, and how many different
yTafII19p and Not5p complexes there are, are very
interesting questions that can now be addressed.
 |
ACKNOWLEDGEMENTS |
We thank Stéphane Jacquier for the
purification of recombinant yTafII19p and Nicole Paquet for
expert technical assistance in all of the biochemical experiments. We
also thank Brice Petit and Caroline Raveraud for technical assistance.
We thank Joe Reese and Anthony Weil for yTafII and TBP
antibodies, Matthias Mayer for pMPM272, Ursula Oberholzer for strains
and plasmids, and Clyde Denis for B42-Ccr4 and B42-Caf1 expression
plasmids. We thank members of our laboratory for fruitful discussions.
 |
FOOTNOTES |
*
This work was supported by Swiss National Science Foundation
Grants 31-39690.93 and 31-49808.96 (to M. A. C.) and by Grant OFES96.0072 TMR (to M. A. C.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Université Claude Bernard, Unité de
Microbiologie et Génétique, Génétique des
Levures, Bt 405 R2, 43 Boulevard du 11 Novembre 1918, 69622 Villeurbanne Cedex, France.
§
To whom correspondence should be addressed. Tel.: 41-22-702-55-16;
Fax: 41-22-702-55-02; E-mail: martine.collart@medecine.unige.ch.
Published, JBC Papers in Press, June 22, 2000, DOI 10.1074/jbc.M002701200
2
M. A. Collart, unpublished
observations..
 |
ABBREVIATIONS |
The abbreviations used are:
TBP, TATA-binding
protein;
PCR, polymerase chain reaction;
ORF, open reading frame;
GST, glutathione S-transferase;
PAGE, polyacrylamide gel
electrophoresis;
TFIID, transcription factor IID.
 |
REFERENCES |
| 1.
|
Conaway, R. C.,
and Conaway, J. W.
(1993)
Annu. Rev. Biochem.
62,
161-190
|
| 2.
|
Hernandez, N.
(1993)
Genes Dev.
7,
1291-1308
|
| 3.
|
Burley, S. K.,
and Roeder, R. G.
(1996)
Annu. Rev. Biochem.
65,
769-799
|
| 4.
|
Grant, P. A.,
Schieltz, D.,
Pray-Grant, M. G.,
Steger, D. J.,
Reese, J. C.,
Yates, J. R., III,
and Workman, J. L.
(1998)
Cell
94,
45-53
|
| 5.
|
Wieczorek, E.,
Brand, M.,
Jacq, X.,
and Tora, L.
(1998)
Nature
393,
187-191
|
| 6.
|
Brand, M.,
Yamamoto, K.,
Staub, A.,
and Tora, L.
(1999)
J. Biol. Chem.
274,
18285-18289
|
| 7.
|
Ogryzko, V. V.,
Kotani, T.,
Zhang, X.,
Schiltz, L. R.,
Howard, T.,
Yang, X.-J.,
Howard, B. H.,
Qin, J.,
and Nakatani, Y.
(1998)
Cell
94,
35-44
|
| 8.
|
Struhl, K.,
and Moqtaderi, Z.
(1998)
Cell
94,
1-4
|
| 9.
|
Hahn, S.
(1998)
Cell
95,
579-582
|
| 10.
|
Chen, W.,
and Struhl, K.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
2691-2695
|
| 11.
|
Mahadevan, S.,
and Struhl, K.
(1990)
Mol. Cell. Biol.
10,
4447-4455
|
| 12.
|
Moqtaderi, Z.,
Bai, Y.,
Poon, D.,
Weil, A. P.,
and Struhl, K.
(1996)
Nature
383,
188-191
|
| 13.
|
Moqtaderi, Z.,
Keaveney, M.,
and Struhl, K.
(1998)
Mol. Cell
2,
675-682
|
| 14.
|
Komarnitsky, P. B.,
Michel, B.,
and Buratowski, S.
(1999)
Genes Dev.
13,
2484-2489
|
| 15.
|
Birck, C.,
Poch, O.,
Romier, C.,
Ruff, M.,
Mengus, G.,
Lavigne, A.-C.,
Davidson, I.,
and Moras, D.
(1998)
Cell
94,
239-249
|
| 16.
|
Oberholzer, U.,
and Collart, M. A.
(1998)
Gene
207,
61-69
|
| 17.
|
Collart, M. A.,
and Struhl, K.
(1993)
EMBO J.
12,
177-186
|
| 18.
|
Collart, M. A.,
and Struhl, K.
(1994)
Genes Dev.
8,
525-537
|
| 19.
|
Liu, H.-Y.,
Badarinarayana, V.,
Audino, D. C.,
Rappsilber, J.,
Mann, M.,
and Denis, C. L.
(1998)
EMBO J.
17,
1096-1106
|
| 20.
|
Lee, T. I.,
Wyrick, J. J.,
Koh, S. S.,
Jennings, E. G.,
Gadbois, E. L.,
and Young, R. A.
(1998)
Mol. Cell. Biol.
18,
4455-4462
|
| 21.
|
Collart, M. A.
(1996)
Mol. Cell. Biol.
16,
6668-6676
|
| 22.
|
Benson, J. D.,
Benson, M.,
Howley, P. M.,
and Struhl, K.
(1998)
EMBO J.
17,
6714-6722
|
| 23.
|
Wach, A.,
Brachat, A.,
Pohlmann, R.,
and Philippsen, P.
(1994)
Yeast
10,
1793-1808
|
| 24.
|
Chevray, P. M.,
and Nathans, D.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
5789-5793
|
| 25.
|
Zervos, A. S.,
Gyuris, J.,
and Brent, R.
(1993)
Cell
72,
223-232
|
| 26.
|
Klebanow, E. R.,
Poon, D.,
Zhou, S.,
and Weil, A. P.
(1997)
J. Biol. Chem.
272,
9436-9442
|
| 27.
|
Cormack, B. P.,
and Struhl, K.
(1992)
Cell
69,
685-696
|
| 28.
|
Yaffee, M. P.,
and Schatz, G.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
4819-4823
|
| 29.
|
Woontner, M.,
Wade, P. A.,
Bonner, J.,
and Jaehning, J. A.
(1991)
Mol. Cell. Biol.
11,
4555-4560
|
| 30.
|
Pellman, D.,
McLaughlin, M. E.,
and Fink, G. R.
(1990)
Nature
348,
82-85
|
| 31.
|
Remacle, J. E.,
and Holmberg, S.
(1992)
Mol. Cell. Biol.
12,
5516-5526
|
| 32.
|
Sanders, S. L.,
Klebanow, E. R.,
and Weil, A. P.
(1999)
J. Biol. Chem.
274,
18847-18850
|
| 33.
|
Poon, D.,
Campbell, A. M.,
Bai, Y.,
and Weil, A. P.
(1994)
J. Biol. Chem.
269,
23135-23140
|
| 34.
|
Alberts, T. K.,
Lemaire, M.,
van Berkum, N. L.,
Gentz, R.,
Collart, M. A.,
and Timmers, M. H. T.
(2000)
Nucleic Acids Res.
28,
809-817
|
| 35.
|
Hope, I.,
and Struhl, K.
(1986)
Cell
46,
885-894
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us